Equillium, Inc. Form 8-K Summary
Business Context and Reporting Period
Equillium, Inc. filed a Current Report on Form 8-K under Item 8.01, Other Events. The reported event occurred on February 21, 2024; the filing was signed on February 22, 2024. The company’s common stock trades under the symbol EQ on the Nasdaq Capital Market.
Key Financial and Operating Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other financial statement metrics.
Material Changes Versus the Prior Comparable Period
- Equillium regained compliance with Nasdaq Listing Rule 5450(a)(1), which requires a minimum closing bid price of $1.00 per share for continued listing.
- The company satisfied the requirement by maintaining a closing bid price of at least $1.00 for 10 consecutive business days, through February 20, 2024.
- Nasdaq notified the company of restored compliance on February 21, 2024.
Outlook, Risks, Contingencies, and Unusual Items
- Nasdaq had previously notified Equillium on April 5, 2023 that it was below the minimum bid price requirement.
- In connection with the transfer of its common stock listing from the Nasdaq Global Market to the Nasdaq Capital Market on October 3, 2023, the company received an additional 180-day compliance period.
- The filing addresses listing compliance only and provides no business guidance, financial outlook, or updated operating forecasts.
Facts Investors Should Verify
- Confirm that Equillium’s Nasdaq Capital Market listing remains active and that the stock continues to satisfy the minimum bid price requirement.
- Review subsequent SEC filings for any new Nasdaq notices, additional compliance conditions, or listing-status changes.
- Consult the company’s financial filings for cash runway, financing needs, operating results, and other financial information not included in this 8-K.